tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bicara Therapeutics reports Q2 EPS (50c), consensus (54c)
PremiumThe FlyBicara Therapeutics reports Q2 EPS (50c), consensus (54c)
12d ago
Bicara Therapeutics expects cash to fund operations into 1H of 2029
Premium
The Fly
Bicara Therapeutics expects cash to fund operations into 1H of 2029
12d ago
Bicara Therapeutics Elects New Directors at Annual Meeting
Premium
Company Announcements
Bicara Therapeutics Elects New Directors at Annual Meeting
2M ago
Wells upgrades Bicara to Equal Weight with thesis played out
PremiumThe FlyWells upgrades Bicara to Equal Weight with thesis played out
3M ago
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
Premium
The Fly
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
3M ago
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
Premium
The Fly
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
3M ago
Bicara Therapeutics publishes updated data from Phase 1/1b trial of Ficerafusp
PremiumThe FlyBicara Therapeutics publishes updated data from Phase 1/1b trial of Ficerafusp
3M ago
Bicara Therapeutics Inc.: Promising Clinical Trials and Stable Financial Outlook Support Buy Rating
Premium
Ratings
Bicara Therapeutics Inc.: Promising Clinical Trials and Stable Financial Outlook Support Buy Rating
3M ago
Bicara Therapeutics price target lowered to $41 from $44 at H.C. Wainwright
Premium
The Fly
Bicara Therapeutics price target lowered to $41 from $44 at H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100